Written Behavioural Persuasion Technique Intervention for Hypertension Management

NCT ID: NCT05966597

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

893 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-14

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to examine the feasibility and effectiveness of written behavioural persuasion techniques intervention to encourage treatment initiation and follow-up for hypertension management among the untreated hypertension population of the SEACO cohort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each household is given a unique identifier called house\_id in the SEACO database. The randomisation will be computer-generated according to their house\_id with a ratio of 1:1. During the house visit, participants' blood pressure will be taken three times, and the final reading will be the average of the second and third readings. Participants will be assessed based on the inclusion and exclusion criteria, i.e., age 35 years and above, blood pressure reading and reported not being diagnosed with or treated for hypertension. At the end of the house visit, all participants will receive a standard referral leaflet, and participants randomised to the intervention group will receive an additional written behavioural persuasion leaflet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Behavior and Behavior Mechanisms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Written persuasive leaflet

Participants will receive a written persuasive leaflet in addition to the standard referral leaflet.

Group Type EXPERIMENTAL

Written persuasive leaflet

Intervention Type BEHAVIORAL

Additional written behavioural persuasive technique leaflet and a standard referral leaflet provided at the end of the home-based health screening.

Standard referral leaflet

Intervention Type BEHAVIORAL

Standard referral leaflet provided at the end of the home-based health screening.

Standard referral leaflet

Participants will receive a standard referral leaflet.

Group Type SHAM_COMPARATOR

Standard referral leaflet

Intervention Type BEHAVIORAL

Standard referral leaflet provided at the end of the home-based health screening.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Written persuasive leaflet

Additional written behavioural persuasive technique leaflet and a standard referral leaflet provided at the end of the home-based health screening.

Intervention Type BEHAVIORAL

Standard referral leaflet

Standard referral leaflet provided at the end of the home-based health screening.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 35 and above
* Systolic blood pressure equal to or more than 140 mmHg
* Diastolic blood pressure equal to or more than 90 mmHg
* reported not being diagnosed with hypertension OR not being treated for hypertension

Exclusion Criteria

* Involve in other research projects
* decline to participate/reject
Minimum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Monash University

OTHER

Sponsor Role collaborator

Monash University Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tin Tin Su

Director of SEACO & Professor Global Public Health

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tin Tin Su

Role: PRINCIPAL_INVESTIGATOR

Monash University Malaysia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

South East Asia Community Observatory, Monash University Malaysia

Segamat, Johor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

References

Explore related publications, articles, or registry entries linked to this study.

Duong TV, Aringazina A, Kayupova G, Nurjanah, Pham TV, Pham KM, Truong TQ, Nguyen KT, Oo WM, Su TT, Majid HA, Sorensen K, Lin IF, Chang Y, Yang SH, Chang PWS. Development and Validation of a New Short-Form Health Literacy Instrument (HLS-SF12) for the General Public in Six Asian Countries. Health Lit Res Pract. 2019 Apr 10;3(2):e91-e102. doi: 10.3928/24748307-20190225-01. eCollection 2019 Apr.

Reference Type BACKGROUND
PMID: 31294310 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MUHREC38735

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.